PRESS RELEASE

Q3 2021 — Press release

Q3 2021PDF · 12 pages611 KB
TransUnion Announces Strong Third Quarter 2021 Results
Š Delivered strong financial performance as a result of business wins, successful innovation and ongoing market recovery.
Š Increased our full year 2021 financial guidance to reflect third quarter out-performance and continued improvement in the global
macro-economic environment.
Š Announced our intent to acquire Neustar, a premier identity resolution company; the transaction is expected to close in the fourth
quarter.
Š Today, announced our intent to acquire Sontiq, a leading provider of consumer identity protection services; the transaction is
expected to close in the fourth quarter.
Š Today, announced our intent to sell our Healthcare business; the transaction is targeted to close in the fourth quarter.
CHICAGO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) (the “Company”) today announced financial results for the
quarter ended September 30, 2021.
Third Quarter 2021 Results
Revenue:
Š Total revenue for the quarter was $792 million, an increase of 14 percent (13 percent on a constant currency basis, 12 percent on an
organic constant currency basis) compared with the third quarter of 2020.
Earnings:
Š Net income attributable to TransUnion was $114 million for the quarter, compared with $103 million for the third quarter of 2020.
Diluted earnings per share was $0.59, compared with $0.53 for the third quarter of 2020.
Š Adjusted Net Income was $194 million for the quarter, compared with $156 million for the third quarter of 2020. Adjusted Diluted
Earnings per Share for the quarter was $1.01, compared with $0.81 for the third quarter of 2020.
Š Adjusted EBITDA was $327 million for the quarter, an increase of 21 percent (20 percent on a constant currency basis, 20 percent on
an organic constant currency basis) compared with the third quarter of 2020. Adjusted EBITDA margin was 41.3 percent, compared
with 38.8 percent for the third quarter of 2020.
“TransUnion delivered another strong quarter as the company benefited from new business wins, product innovation and broad market
recovery,” said Chris Cartwright, President and CEO. “We also announced important strategic transactions that further position TransUnion
for long-term growth as we focus on improving identity verification and targeting precision to enable safe, tailored consumer experiences.
Notably, we agreed to acquire Neustar, a premier identity resolution company with leading solutions in Marketing, Fraud and
Communications. We also recently made investments in and established commercial agreements with Monevo, which delivers online pre-
qualification services primarily in the U.K. and the U.S., and IDfy, an India-based provider of online identity verification, authentication and
onboarding solutions.”
“And, today, we announced our intent to acquire Sontiq, which complements and expands our Consumer Interactive solutions portfolio by
providing valuable identity protection for consumers. We also announced an agreement to sell our Healthcare business, which will provide
significant net proceeds to help fund the strategic acquisitions we’ve announced, as well as allow the Healthcare business to benefit from
ownership whose priorities are solely focused on healthcare revenue cycle management.”
“These strategic moves further strengthen our portfolio, create new growth vectors, and position TransUnion for attractive long-term
growth.”
Third Quarter 2021 Segment Results
U.S. Markets:
U.S. Markets revenue was $498 million, an increase of 14 percent (12 percent on an organic basis) compared with the third quarter of 2020.
Š Financial Services revenue was $278 million, an increase of 11 percent compared with the third quarter of 2020.
Š Emerging Verticals revenue, which includes Healthcare, Insurance and all other verticals, was $221 million, an increase of 17 percent
(14 percent on an organic basis) compared with the third quarter of 2020.
Adjusted EBITDA was $210 million, an increase of 19 percent (19 percent on an organic basis) compared with the third quarter of 2020.
International:
International revenue was $178 million, an increase of 23 percent (18 percent on a constant currency basis) compared with the third quarter
of 2020.
Š Canada revenue was $31 million, an increase of 10 percent (4 percent on a constant currency basis) compared with the third quarter
of 2020.
Š Latin America revenue was $27 million, an increase of 23 percent (22 percent on a constant currency basis) compared with the third

-- 1 of 12 --

quarter of 2020.
Š United Kingdom revenue was $55 million, an increase of 24 percent (16 percent on a constant currency basis) compared with the
third quarter of 2020.
Š Africa revenue was $15 million, an increase of 23 percent (8 percent on a constant currency basis) compared with the third quarter of
2020.
Š India revenue was $35 million, an increase of 44 percent (44 percent on a constant currency basis) compared with the third quarter of
2020.
Š Asia Pacific revenue was $16 million, an increase of 10 percent (11 percent on a constant currency basis) compared with the third
quarter of 2020.
Adjusted EBITDA was $78 million, an increase of 37 percent (31 percent on a constant currency basis) compared with the third quarter of
2020.
Consumer Interactive:
Consumer Interactive revenue was $135 million, an increase of 3 percent compared with the third quarter of 2020.
Adjusted EBITDA was $69 million, an increase of 4 percent compared with the third quarter of 2020.
Liquidity and Capital Resources
Cash and cash equivalents were $709 million at September 30, 2021 and $493 million at December 31, 2020. In addition, we had $300
million of undrawn capacity on our Senior Secured Revolving Credit Facility. For the nine months ended September 30, 2021, cash
provided by continuing operations was $660 million compared with $558 million in 2020. The increase in cash provided by operations was
due primarily to an increase in operating performance and a decrease in interest expense, partially offset by an increase in working capital.
Cash used in investing activities was $208 million compared with $154 million in 2020. The increase in cash used in investing activities was
due primarily to an increase in investments in nonconsolidated affiliates and purchases of convertible notes, and an increase in capital
expenditures. Capital expenditures were $158 million compared with $132 million in 2020. Cash used in financing activities was $232 million
compared with $110 million in 2020. The increase in cash used in financing activities was due primarily to $85.0 million debt prepayments
made in 2021 and an increase in the payments for contingent consideration in 2021.
Recently Announced Transactions
On September 13, 2021, we announced our agreement to acquire Neustar, Inc. (“Neustar”) for $3.1 billion in cash, subject to customary
purchase price adjustments. We intend to finance the acquisition through a combination of debt financing and cash on hand, and have
entered into a debt commitment letter which provides for a senior secured term loan facility in an aggregate principal amount of up to $3.1
billion. We expect the acquisition to close in the fourth quarter of 2021, subject to the satisfaction of customary closing conditions and
regulatory approvals. For additional information on our acquisition of Neustar, refer to our Press Release dated September 13, 2021, which
is available on our Investor Relations website at https://investors.transunion.com/.
Today, we announced our agreement to acquire Sontiq, Inc. (“Sontiq”) for $638 million in cash, subject to customary purchase price
adjustments. We intend to finance the acquisition through a combination of debt financing and cash on hand, and have entered into a debt
commitment letter which provides for a new secured term loan facility in an aggregate principal amount of up to $640 million. We expect the
acquisition to close in the fourth quarter of 2021, subject to the satisfaction of customary closing conditions and regulatory approvals. For
additional information on our acquisition of Sontiq, refer to our Press Release dated October 26, 2021, which is available on our Investor
Relations website at https://investors.transunion.com/.
Today, we also announced our agreement to sell our Healthcare business for $1.735 billion in cash, subject to customary purchase price
adjustments. We intend to use the net proceeds from this sale to prepay debt and for other general corporate purposes as permitted under
the Senior Secured Credit Facilities. We are targeting closing in the fourth quarter of 2021, subject to the satisfaction of customary closing
conditions and regulatory approvals. For additional information on the divestment of our Healthcare business, refer to our Press Release
dated October 26, 2021, which is available on our Investor Relations website at https://investors.transunion.com/.
Fourth Quarter and Full Year 2021 Outlook
Our guidance is based on a number of assumptions that are subject to change, many of which are outside of the control of the Company,
including general macroeconomic conditions and the potential impact of the global COVID-19 pandemic. There are numerous evolving
factors that we may not be able to accurately predict. There can be no assurance that the Company will achieve the results expressed by
this guidance.
Three Months Ended
December 31, 2021
Twelve Months Ended
December 31, 2021
Dollars in millions, except per share data 	Low 	High 	Low 	High
Revenue, as reported 	$764 	$774 	$3,075 	$3,085
Revenue growth1:
As reported 	9% 	11% 	13% 	14%
Constant currency1, 3 	9% 	11% 	12% 	13%
Organic constant currency1, 4 	9% 	11% 	12% 	12%
Net income attributable to TransUnion 	$72 	$78 	$441 	$448

-- 2 of 12 --

Earnings Webcast Details
In conjunction with this release, TransUnion will host a conference call and webcast today at 8:30 a.m. Central Time to discuss the
business results for the quarter and certain forward-looking information. This session and the accompanying presentation materials may be
accessed at www.transunion.com/tru. A replay of the call will also be available at this website following the conclusion of the call.
About TransUnion
TransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing a
comprehensive picture of each person so they can be reliably and safely represented in the marketplace. As a result, businesses and
consumers can transact with confidence and achieve great things. We call this Information for Good.
A leading presence in more than 30 countries across five continents, TransUnion provides solutions that help create economic opportunity,
great experiences and personal empowerment for hundreds of millions of people.
http://www.transunion.com/business
Availability of Information on TransUnion’s Website
Investors and others should note that TransUnion routinely announces material information to investors and the marketplace using SEC
filings, press releases, public conference calls, webcasts and the TransUnion Investor Relations website. While not all of the information
that the Company posts to the TransUnion Investor Relations website is of a material nature, some information could be deemed to be
material. Accordingly, the Company encourages investors, the media and others interested in TransUnion to review the information that it
shares on www.transunion.com/tru.
Non-GAAP Financial Measures
This earnings release presents constant currency growth rates assuming foreign currency exchange rates are consistent between years.
This allows financial results to be evaluated without the impact of fluctuations in foreign currency exchange rates. This earnings release
also presents organic constant currency growth rates, which assumes consistent foreign currency exchange rates between years and also
eliminates the impact of our recent acquisitions. This allows financial results to be evaluated without the impact of fluctuations in foreign
currency exchange rates and the impacts of recent acquisitions.
This earnings release also presents Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Effective Tax Rate, Adjusted Net Income (Loss)
and Adjusted Diluted Earnings per Share for all periods presented. These are important financial measures for the Company but are not
financial measures as defined by GAAP. We present Adjusted EBITDA and Adjusted Net Income as supplemental measures of our
operating performance because these measures eliminate the impact of certain items that we do not consider indicative of our cash
operations and ongoing operating performance. Adjusted EBITDA is also a measure frequently used by securities analysts, investors and
Net income attributable to TransUnion growth 	(29)% 	(23)% 	29% 	31%
Diluted Earnings per Share 	$0.37 	$0.40 	$2.29 	$2.32
Diluted Earnings per Share growth 	(30)% 	(24)% 	28% 	30%
Adjusted EBITDA, as reported5 	$293 	$301 	$1,239 	$1,247
Adjusted EBITDA growth, as reported2 9% 	12% 	19% 	19%
Adjusted Diluted Earnings per Share5 	$0.88 	$0.91 	$3.76 	$3.79
Adjusted Earnings per Share growth 	10% 	14% 	25% 	26%
(1) Additional revenue growth assumptions:
a. The impact of changing foreign currency exchange rates is expected to have an immaterial impact for Q4 2021 and
approximately 1.0 point of benefit for FY 2021.
b. The impact of recent acquisitions is expected to have no impact for Q4 2021 and approximately 1.0 point of benefit for
FY 2021.
c. The impact of mortgage is expected to be approximately 4.0 points of headwind for Q4 2021 and 2.0 points of
headwind for FY 2021. These impacts are calculated by removing the U.S. mortgage revenue from both the current year
and prior year periods.
(2) Additional Adjusted EBITDA assumptions:
a. The impact of changing foreign currency exchange rates is expected to be immaterial for Q4 2021 and approximately
1.0 point of benefit for FY 2021.
(3) Constant currency growth rates assume foreign currency exchange rates are consistent between years. This allows financial
results to be evaluated without the impact of fluctuations in foreign currency exchange rates.
(4) Organic constant currency growth rates are constant currency growth excluding inorganic growth. Inorganic growth represents
growth attributable to the first twelve months of activity for recent business acquisitions.
(5) For a reconciliation of the above non-GAAP financial measures to the most directly comparable GAAP financial measures,
refer to Schedule 6 of this Earnings Release.

-- 3 of 12 --

other interested parties in their evaluation of the operating performance of companies similar to ours. Our board of directors and executive
management team use Adjusted EBITDA as compensation measures. Under the credit agreement governing our Senior Secured Credit
Facility, our ability to engage in activities such as incurring additional indebtedness, making investments and paying dividends is tied to a
ratio based on Adjusted EBITDA. These financial measures should be reviewed in conjunction with the relevant GAAP financial measures
and are not presented as alternative measures of GAAP. Other companies in our industry may define or calculate these measures
differently than we do, limiting their usefulness as comparative measures. Because of these limitations, these non-GAAP financial
measures should not be considered in isolation or as substitutes for performance measures calculated in accordance with GAAP, including
operating income, operating margin, effective tax rate, net income (loss) attributable to the Company, earnings per share or cash provided
by operating activities. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures
are presented in the attached Schedules.
We define Adjusted EBITDA as net income (loss) attributable to TransUnion plus net interest expense, plus (less) provision (benefit) for
income taxes, plus depreciation and amortization, plus stock-based compensation, plus mergers, acquisitions, divestitures and business
optimization-related expenses, plus certain accelerated technology investment expenses to migrate to the cloud, plus (less) certain other
expenses (income). We define Adjusted Net Income as net income (loss) attributable to TransUnion plus stock-based compensation, plus
mergers, acquisitions, divestitures and business optimization-related expenses, plus certain accelerated technology investment expenses,
plus (less) certain other expenses (income), plus amortization of certain intangible assets, plus or minus the related changes in provision
for income taxes. We define Adjusted Diluted Earnings per Share as Adjusted Net Income divided by the weighted-average diluted shares
outstanding. The above definitions apply to our calculations for the periods shown on Schedules 1 through 6.
Forward-Looking Statements
This earnings release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These statements are based on the current beliefs and expectations of TransUnion’s management and are subject to significant risks and
uncertainties. Actual results may differ materially from those described in the forward-looking statements. Any statements made in this
earnings release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking
statements. Forward-looking statements include information concerning possible or assumed future results of operations, including our
guidance and descriptions of our business plans and strategies. These statements often include words such as “anticipate,” “expect,”
“guidance,” “suggest,” “plan,” “believe,” “intend,” “estimate,” “target,” “project,” “should,” “could,” “would,” “may,” “will,” “forecast,” “outlook,”
“potential,” “continues,” “seeks,” “predicts,” or the negative of these words and other similar expressions. Factors that could cause actual
results to differ materially from those described in the forward-looking statements include: the effects of the COVID-19 pandemic; the
duration of the COVID-19 pandemic and the timing of the recovery from the COVID-19 pandemic; the prevalence and severity of variants of
the COVID-19 virus; macroeconomic and industry trends and adverse developments in the debt, consumer credit and financial services
markets; our ability to provide competitive services and prices; our ability to retain or renew existing agreements with large or long-term
customers; our ability to maintain the security and integrity of our data; our ability to deliver services timely without interruption; our ability to
maintain our access to data sources; government regulation and changes in the regulatory environment; litigation or regulatory
proceedings; regulatory oversight of “critical activities”; our ability to effectively manage our costs; economic and political stability in the
United States and international markets where we operate; our ability to effectively develop and maintain strategic alliances and joint
ventures; our ability to timely develop new services and the market’s willingness to adopt our new services; our ability to manage and
expand our operations and keep up with rapidly changing technologies; failure to realize the synergies and other benefits expected from the
proposed acquisitions of Neustar and Sontiq; delays in closing the proposed acquisitions; the possibility that the proposed acquisitions,
including the integration of Neustar and Sontiq, may be more costly to complete than anticipated; business disruption related to the
proposed acquisitions; the possibility that the expected benefits of the proposed Healthcare divestiture will not be realized, or will not be
realized within the expected time period; failure to obtain governmental approvals of the proposed Healthcare divestiture in the expected
time period, or at all; the impact of the proposed Healthcare divestiture on TransUnion’s businesses and the risk that consummating the
proposed Healthcare divestiture may be more difficult, time-consuming or costly than expected; the possibility that the proposed Healthcare
divestiture does not close, including failure to satisfy the closing conditions; risks related to the distraction of management from ongoing
business operations and other opportunities due to the proposed acquisitions and the proposed Healthcare divestiture; our ability to acquire
businesses, including any recently announced business acquisitions, successfully secure financing for our acquisitions, timely
consummate our acquisitions, successfully integrate the operations of our acquisitions, control the costs of integrating our acquisitions and
realize the intended benefits of such acquisitions; our ability to consummate the sale of our recently announced divestiture on a timely basis
or at all; our ability to protect and enforce our intellectual property, trade secrets and other forms of unpatented intellectual property; our
ability to defend our intellectual property from infringement claims by third parties; the ability of our outside service providers and key
vendors to fulfill their obligations to us; further consolidation in our end-customer markets; the increased availability of free or inexpensive
consumer information; losses against which we do not insure; our ability to make timely payments of principal and interest on our
indebtedness; our ability to satisfy covenants in the agreements governing our indebtedness; our ability to maintain our liquidity; share
repurchase plans; our reliance on key management personnel; and other one-time events and other factors that can be found in our Annual
Report on Form 10-K for the year ended December 31, 2020, and any subsequent Quarterly Report on Form 10-Q or Current Report on
Form 8-K, which are filed with the Securities and Exchange Commission and are available on TransUnion’s website
(www.transunion.com/tru) and on the Securities and Exchange Commission’s website (www.sec.gov). Many of these factors are beyond
our control. The forward-looking statements contained in this earnings release speak only as of the date of this earnings release. We
undertake no obligation to publicly release the result of any revisions to these forward-looking statements to reflect the impact of events or
circumstances that may arise after the date of this earnings release.
In addition to factors previously disclosed in TransUnion’s reports filed with the Securities and Exchange Commission and those identified
elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking
statements or historical performance: failure to realize the benefits expected from the recent business acquisitions; the effects of pending
and future legislation; risks related to disruption of management time from ongoing business operations due to the recent business
acquisitions; macroeconomic factors beyond TransUnion’s control; risks related to TransUnion’s indebtedness and other consequences
associated with mergers, acquisitions and divestitures, and legislative and regulatory actions and reforms.
For More Information
E-mail: 	Investor.Relations@transunion.com

-- 4 of 12 --

Telephone: 	312.985.2860
TRANSUNION AND SUBSIDIARIES
Consolidated Balance Sheets (Unaudited)
(in millions, except per share data)
September 30,
2021
December 31,
2020
Assets
Current assets:
Cash and cash equivalents 	$ 	708.8 $ 	493.0
Trade accounts receivable, net of allowance of $23.9 and $26.6 	513.6 	453.7
Other current assets 	228.2 	159.5
Total current assets 	1,450.6 	1,106.2
Property, plant and equipment, net of accumulated depreciation and amortization of
$622.0 and $548.9 	196.4 	223.2
Goodwill 	3,424.7 	3,461.5
Other intangibles, net of accumulated amortization of $1,945.8 and $1,752.2 	2,161.2 	2,284.6
Other assets 	275.5 	236.1
Total assets 	$ 	7,508.4 $ 	7,311.6
Liabilities and stockholders’ equity
Current liabilities:
Trade accounts payable 	$ 	227.7 $ 	193.2
Short-term debt and current portion of long-term debt 	76.5 	55.5
Other current liabilities 	375.8 	415.8
Total current liabilities 	680.0 	664.5
Long-term debt 	3,253.1 	3,398.7
Deferred taxes 	419.8 	396.8
Other liabilities 	174.3 	215.5
Total liabilities 	4,527.2 	4,675.5
Stockholders’ equity:
Common stock, $0.01 par value; 1.0 billion shares authorized at September 30, 2021
and December 31, 2020, 197.2 million and 195.7 million shares issued at
September 30, 2021 and December 31, 2020, respectively, and 191.6 million shares
and 190.5 million shares outstanding as of September 30, 2021 and December 31,
2020, respectively 	2.0 	2.0
Additional paid-in capital 	2,161.5 	2,088.1
Treasury stock at cost; 5.6 million and 5.2 million shares at September 30, 2021 and
December 31, 2020, respectively 	(250.1) 	(215.2)
Retained earnings 	1,255.7 	937.4
Accumulated other comprehensive loss 	(288.3) 	(272.1)
Total TransUnion stockholders’ equity 	2,880.8 	2,540.2
Noncontrolling interests 	100.4 	95.9
Total stockholders’ equity 	2,981.2 	2,636.1
Total liabilities and stockholders’ equity 	$ 	7,508.4 $ 	7,311.6
TRANSUNION AND SUBSIDIARIES
Consolidated Statements of Income (Unaudited)
(in millions, except per share data)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021 	2020 	2021 	2020
Revenue 	$ 	791.6 $ 	695.9 $ 	2,311.1 $ 	2,017.9
Operating expenses
Cost of services (exclusive of depreciation and amortization
below) 	259.1 	222.4 	752.6 	666.1
Selling, general and administrative 	247.3 	219.0 	682.4 	655.4
Depreciation and amortization 	95.9 	92.2 	288.6 	273.4
Total operating expenses 	602.3 	533.6 	1,723.6 	1,594.9

-- 5 of 12 --

As a result of displaying amounts in millions, rounding differences may exist in the table above.
Operating income 	189.4 	162.3 	587.5 	423.0
Non-operating income and (expense)
Interest expense 	(25.7) 	(27.6) 	(77.1) 	(98.7)
Interest income 	1.0 	1.2 	2.5 	4.2
Earnings from equity method investments 	2.9 	2.1 	8.6 	6.7
Other income and (expense), net 	(10.3) 	0.8 	(10.8) 	(6.9)
Total non-operating income and (expense) 	(32.2) 	(23.6) 	(76.8) 	(94.7)
Income before income taxes 	157.2 	138.7 	510.7 	328.3
Provision for income taxes 	(39.0) 	(32.1) 	(129.1) 	(77.3)
Net income 	118.2 	106.7 	381.7 	251.0
Less: net (income) loss attributable to the noncontrolling
interests 	(4.0) 	(3.9) 	(12.0) 	(9.5)
Net income attributable to TransUnion 	$ 	114.2 $ 	102.8 $ 	369.7 $ 	241.5
Weighted-average shares outstanding:
Basic 	191.6 	190.2 	191.3 	189.8
Diluted 	193.1 	192.3 	192.9 	192.1
Earnings Per Share:
Basic 	$ 	0.60 $ 	0.54 $ 	1.93 $ 	1.27
Diluted 	$ 	0.59 $ 	0.53 $ 	1.92 $ 	1.26
TRANSUNION AND SUBSIDIARIES
Consolidated Statements of Cash Flows (Unaudited)
(in millions)
Nine Months Ended September 30,
2021 	2020
Cash flows from operating activities:
Net income 	$ 	381.7 $ 	251.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 	288.6 	273.4
Net (gain) loss on investments in affiliated companies and other investments 	(12.3) 	0.5
Deferred taxes 	13.2 	(25.2)
Stock-based compensation 	51.6 	29.6
Provision for losses on trade accounts receivable 	0.7 	11.4
Other 	1.0 	6.1
Changes in assets and liabilities:
Trade accounts receivable 	(63.2) 	(43.4)
Other current and long-term assets 	(40.5) 	(9.6)
Trade accounts payable 	35.6 	7.3
Other current and long-term liabilities 	3.8 	57.1
Cash provided by operating activities 	$ 	660.2 $ 	558.2
Cash flows from investing activities:
Capital expenditures 	(158.1) 	(131.7)
Proceeds from sale/maturities of other investments 	27.8 	52.3
Purchases of other investments 	(53.7) 	(65.0)
Investments in nonconsolidated affiliates and purchases of convertible notes 	(41.6) 	(12.3)
Proceeds from disposals of investments and assets held for sale 	18.7 	1.6
Other 	(1.1) 	1.6
Cash used in investing activities 	$ 	(208.0) $ 	(153.5)
Cash flows from financing activities:
Repayments of debt 	(127.5) 	(45.0)
Proceeds from issuance of common stock and exercise of stock options 	21.2 	21.7
Dividends to shareholders 	(51.5) 	(43.3)
Employee taxes paid on restricted stock units recorded as treasury stock 	(34.8) 	(35.5)
Payment of contingent consideration 	(32.4) 	(6.4)
Distributions to noncontrolling interests 	(6.5) 	(1.4)
Cash used in financing activities 	$ 	(231.5) $ 	(109.9)
Effect of exchange rate changes on cash and cash equivalents 	(4.9) 	(14.9)
Net change in cash and cash equivalents 	$ 	215.8 $ 	279.9

-- 6 of 12 --

As a result of displaying amounts in millions, rounding differences may exist in the table above.
Cash and cash equivalents, beginning of period 	493.0 	274.1
Cash and cash equivalents, end of period 	$ 	708.8 $ 	554.0
SCHEDULE 1
TRANSUNION AND SUBSIDIARIES
Revenue and Adjusted EBITDA growth rates as Reported, CC, Inorganic, Organic and Organic CC (Unaudited)
For the Three Months Ended September 30, 2021 compared with the Three
Months Ended September 30, 2020
Reported 	CC Growth(1) 	Inorganic(2) 	Organic
Growth(3)
Organic CC
Growth(4)
Revenue:
Consolidated 	13.8% 	12.7% 	0.8% 	13.0% 	11.9%
U.S. Markets 	13.7% 	13.7% 	1.2% 	12.4% 	12.4%
Financial Services 	11.5% 	11.5% 	—% 	11.5% 	11.5%
Emerging Verticals 	16.6% 	16.5% 	2.8% 	13.7% 	13.7%
International 	22.9% 	18.0% 	—% 	22.9% 	18.0%
Canada 	9.7% 	3.7% 	—% 	9.7% 	3.7%
Latin America 	22.9% 	22.3% 	—% 	22.9% 	22.3%
United Kingdom 	23.8% 	15.9% 	—% 	23.8% 	15.9%
Africa 	23.3% 	8.5% 	—% 	23.3% 	8.5%
India 	44.2% 	43.6% 	—% 	44.2% 	43.6%
Asia Pacific 	10.4% 	11.1% 	—% 	10.4% 	11.1%
Consumer Interactive 	2.6% 	2.6% 	—% 	2.6% 	2.6%
Adjusted EBITDA:
Consolidated 	21.1% 	19.9% 	(0.5)% 	21.6% 	20.4%
U.S. Markets 	18.6% 	18.6% 	(0.7)% 	19.3% 	19.3%
International 	37.0% 	31.3% 	—% 	37.0% 	31.3%
Consumer Interactive 	3.5% 	3.5% 	—% 	3.5% 	3.5%
SCHEDULE 1
TRANSUNION AND SUBSIDIARIES
Revenue and Adjusted EBITDA growth rates as Reported, CC, Inorganic, Organic and Organic CC (Unaudited)
For the Nine Months Ended September 30, 2021 compared with the Nine
Months Ended September 30, 2020
Reported 	CC Growth(1) 	Inorganic(2) 	Organic
Growth(3)
Organic CC
Growth(4)
Revenue:
Consolidated 	14.5 % 	13.2 % 	0.9% 	13.6 % 	12.4 %
U.S. Markets 	14.6 % 	14.6 % 	1.4% 	13.2 % 	13.2 %
Financial Services 	15.6 % 	15.6 % 	—% 	15.6 % 	15.6 %
Emerging Verticals 	13.4 % 	13.4 % 	3.1% 	10.3 % 	10.2 %
International 	22.4 % 	16.3 % 	—% 	22.4 % 	16.3 %
Canada 	21.0 % 	11.8 % 	—% 	21.0 % 	11.8 %
Latin America 	21.5 % 	22.2 % 	—% 	21.5 % 	22.2 %
United Kingdom 	19.8 % 	9.6 % 	—% 	19.8 % 	9.6 %
Africa 	23.8 % 	10.4 % 	—% 	23.8 % 	10.4 %
India 	33.2 % 	32.2 % 	—% 	33.2 % 	32.2 %
Asia Pacific 	14.2 % 	14.0 % 	—% 	14.2 % 	14.0 %
Consumer Interactive 	3.9 % 	3.9 % 	—% 	3.9 % 	3.9 %
Adjusted EBITDA:
Consolidated 	21.9 % 	20.5 % 	(0.7)% 	22.6 % 	21.2 %
U.S. Markets 	19.0 % 	19.0 % 	(1.1)% 	20.0 % 	20.0 %
International 	43.3 % 	36.0 % 	—% 	43.3 % 	36.0 %

-- 7 of 12 --

Consumer Interactive 	3.5 % 	3.5 % 	—% 	3.5 % 	3.5 %
(1) Constant Currency (“CC”) growth rates assume foreign currency exchange rates are consistent between years. This allows
financial results to be evaluated without the impact of fluctuations in foreign currency exchange rates.
(2) Inorganic growth rate represents growth attributable to the first twelve months of activity for recent business acquisitions.
(3) Organic growth rate is the reported growth rate less the inorganic growth rate.
(4) Organic CC growth rate is the CC growth rate less inorganic growth rate.
SCHEDULE 2
TRANSUNION AND SUBSIDIARIES
Consolidated and Segment Revenue, Adjusted EBITDA, and Adjusted EBITDA Margins (Unaudited)
(dollars in millions)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021 	2020 	2021 	2020
Revenue:
U.S. Markets gross revenue
Financial Services 	$ 	277.6 	$ 	249.1 	$ 	811.4 	$ 	701.7
Emerging Verticals 	220.7 	189.4 	639.8 	564.1
U.S. Markets gross revenue 	$ 	498.4 	$ 	438.5 	$ 	1,451.2 	$ 	1,265.8
International gross revenue
Canada 	$ 	30.6 	$ 	27.9 	$ 	95.0 	$ 	78.5
Latin America 	26.7 	21.7 	76.8 	63.2
United Kingdom 	54.6 	44.2 	158.3 	132.1
Africa 	15.1 	12.3 	44.0 	35.6
India 	34.5 	23.9 	96.4 	72.4
Asia Pacific 	16.5 	14.9 	46.2 	40.5
International gross revenue 	$ 	178.0 	$ 	144.8 	$ 	516.7 	$ 	422.2
Consumer Interactive gross revenue 	$ 	135.0 	$ 	131.6 	$ 	401.9 	$ 	386.7
Total gross revenue 	$ 	811.4 	$ 	714.9 	$ 	2,369.8 	$ 	2,074.8
Intersegment revenue eliminations
U.S. Markets 	$ 	(17.7) $ 	(17.2) $ 	(52.7) $ 	(51.7)
International 	(1.5) 	(1.4) 	(4.4) 	(3.9)
Consumer Interactive 	(0.5) 	(0.5) 	(1.6) 	(1.3)
Total intersegment revenue eliminations 	$ 	(19.7) $ 	(19.0) $ 	(58.7) $ 	(56.8)
Total revenue as reported 	$ 	791.6 	$ 	695.9 	$ 	2,311.1 	$ 	2,017.9
Adjusted EBITDA:
U.S. Markets 	$ 	210.3 	$ 	177.3 	$ 	618.6 	$ 	520.0
International 	77.7 	56.7 	221.3 	154.4
Consumer Interactive 	69.4 	67.1 	192.8 	186.2
Corporate 	(30.5) 	(31.2) 	(86.7) 	(84.7)
Consolidated Adjusted EBITDA 	$ 	327.0 	$ 	269.9 	$ 	945.9 	$ 	775.9
Adjusted EBITDA margin:(1)
U.S. Markets 	42.2% 	40.4% 	42.6% 	41.1%
International 	43.7% 	39.2% 	42.8% 	36.6%
Consumer Interactive 	51.4% 	51.0% 	48.0% 	48.1%
Consolidated 	41.3% 	38.8% 	40.9% 	38.5%
(1) Segment Adjusted EBITDA margins are calculated using segment gross revenue and segment Adjusted EBITDA.
Consolidated Adjusted EBITDA margin is calculated using total revenue as reported and consolidated Adjusted EBITDA.

-- 8 of 12 --

As a result of displaying amounts in millions, rounding differences may exist in the tables above and footnotes below.
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021 	2020 	2021 	2020
Reconciliation of net income attributable to TransUnion
to consolidated Adjusted EBITDA:
Net income attributable to TransUnion 	$ 	114.2 	$ 	102.8 	$ 	369.7 	$ 	241.5
Net interest expense 	24.7 	26.5 	74.6 	94.6
Provision for income taxes 	39.0 	32.1 	129.1 	77.3
Depreciation and amortization 	95.9 	92.2 	288.6 	273.4
EBITDA 	$ 	273.8 	$ 	253.5 	$ 	861.9 	$ 	686.7
Adjustments to EBITDA:
Stock-based compensation(1) 	$ 	17.4 	$ 	7.8 	$ 	51.9 	$ 	29.5
Mergers and acquisitions, divestitures and business
optimization(2) 	10.3 	1.5 	23.4 	12.9
Accelerated technology investment(3) 	12.6 	4.5 	29.7 	10.3
Net other(4) 	12.8 	2.6 	(21.0) 	36.4
Total adjustments to EBITDA 	$ 	53.2 	$ 	16.4 	$ 	84.0 	$ 	89.2
Consolidated Adjusted EBITDA 	$ 	327.0 	$ 	269.9 	$ 	945.9 	$ 	775.9
Net income attributable to TransUnion as a percentage of
revenue 	14.4% 	14.8% 	16.0% 	12.0%
Consolidated Adjusted EBITDA margin 	41.3% 	38.8% 	40.9% 	38.5%
(1) Consisted of stock-based compensation and cash-settled stock-based compensation.
(2) For the three months ended September 30, 2021, consisted of the following adjustments: $22.7 million of acquisition
expenses; $0.5 million of adjustments to contingent consideration expense from previous acquisitions; and a ($12.9) million
gain on the sale of a Cost Method investment.
For the nine months ended September 30, 2021, consisted of the following adjustments: $27.4 million of acquisition expenses;
$8.3 million of adjustments to contingent consideration expense from previous acquisitions; $1.1 million gain reduction to notes
receivable that were converted into equity upon acquisition and consolidation of an entity; and ($13.4) million gain on the sale
of Cost Method investments.
For the three months ended September 30, 2020, consisted of the following adjustments: $1.5 million of acquisition expenses.
For the nine months ended September 30, 2020, consisted of the following adjustments: $7.5 million of Callcredit integration
costs; a $4.8 million loss on the impairment of a Cost Method investment; $4.8 million of acquisition expenses; $0.3 million of
adjustments to contingent consideration expense from previous acquisitions; a $(2.5) million gain on a Cost Method investment
resulting from an observable price change for a similar investment of the same issuer; a $(1.8) million gain on the disposal of
assets of a small business in our United Kingdom region that are classified as held-for-sale; and a $(0.1) million
reimbursement for transition services provided to the buyers of certain of our discontinued operations.
(3) Represents expenses associated with our accelerated technology investment.
(4) For the three months ended September 30, 2021, net other of $12.8 million consisted of the following adjustments: $12.0
million for certain legal and regulatory expenses; and a $0.8 million net loss from currency remeasurement of our foreign
operations, loan fees and other.
For the nine months ended September 30, 2021, consisted of the following adjustments: a $(20.4) million net reduction in
certain legal and regulatory expenses; a $(3.4) million recovery from the Fraud Incident, net of additional administrative
expense; and $2.8 million of net other consisting of net losses from currency remeasurement of our foreign operations, loan
fees and other.
For the three months ended September 30, 2020, consisted of the following adjustments: $4.2 million for certain legal
expenses; and $(1.6) million of net other consisting of loan fees, net gains from currency remeasurement of our foreign
operations and other.
For the nine months ended September 30, 2020, consisted of the following adjustments: $34.7 million for certain legal
expenses; a $1.6 million of net other consisting of net losses from currency remeasurement of our foreign operation, loan fees
and other.
SCHEDULE 3
TRANSUNION AND SUBSIDIARIES
Adjusted Net Income and Adjusted Earnings Per Share (Unaudited)
(in millions, except per share data)
Three Months Ended 	Nine Months Ended

-- 9 of 12 --

As a result of displaying amounts in millions, rounding differences may exist in the table above and footnotes below.
September 30, 	September 30,
2021 	2020 	2021 	2020
Net income attributable to TransUnion 	$ 	114.2 $ 	102.8 $ 	369.7 $ 	241.5
Weighted-average shares outstanding:
Basic 	191.6 	190.2 	191.3 	189.8
Diluted 	193.1 	192.3 	192.9 	192.1
Earnings per share:
Basic 	$ 	0.60 $ 	0.54 $ 	1.93 $ 	1.27
Diluted 	$ 	0.59 $ 	0.53 $ 	1.92 $ 	1.26
Reconciliation of net income attributable to TransUnion
to Adjusted Net Income:
Net income attributable to TransUnion 	$ 	114.2 $ 	102.8 $ 	369.7 $ 	241.5
Adjustments before income tax items:
Stock-based compensation(1) 	17.4 	7.8 	51.9 	29.5
Mergers and acquisitions, divestitures and business
optimization(2) 	10.3 	1.5 	23.4 	12.9
Accelerated technology investment(3) 	12.6 	4.5 	29.7 	10.3
Net other(4) 	12.4 	2.5 	(22.1) 	35.5
Amortization of certain intangible assets(5) 	47.3 	48.1 	142.7 	144.7
Total adjustments before income tax items 	$ 	100.0 $ 	64.4 $ 	225.6 $ 	232.9
Change in provision for income taxes per schedule 4 	(19.9) 	(11.1) 	(39.8) 	(50.6)
Adjusted Net Income 	$ 	194.3 $ 	156.2 $ 	555.5 $ 	423.8
Weighted-average shares outstanding(6):
Basic 	191.6 	190.2 	191.3 	189.8
Diluted 	193.1 	192.3 	192.9 	192.1
Adjusted Earnings per Share:
Basic 	$ 	1.01 $ 	0.82 $ 	2.90 $ 	2.23
Diluted 	$ 	1.01 $ 	0.81 $ 	2.88 $ 	2.21
Anti-dilutive weighted stock-based awards outstanding 	— 	0.1 	— 	0.3
(1) Consisted of stock-based compensation and cash-settled stock-based compensation.
(2) For the three months ended September 30, 2021, consisted of the following adjustments: $22.7 million of acquisition
expenses; $0.5 million of adjustments to contingent consideration expense from previous acquisitions; and a ($12.9) million
gain on the sale of a Cost Method investment.
For the nine months ended September 30, 2021, consisted of the following adjustments: $8.3 million of adjustments to
contingent consideration expense from previous acquisitions; $27.4 million of acquisition expenses; a $1.1 million gain
reduction to notes receivable that were converted into equity upon acquisition and consolidation of an entity; and ($13.4) million
gain on the sale of Cost Method investments.
For the three months ended September 30, 2020, consisted of the following adjustments: $1.5 million of acquisition expenses.
For the nine months ended September 30, 2020, consisted of the following adjustments: $7.5 million of Callcredit integration
costs; a $4.8 million loss on the impairment of a Cost Method investment; $4.8 million of acquisition expenses; $0.3 million of
adjustments to contingent consideration expense from previous acquisitions; a $(2.5) million gain on a Cost Method investment
resulting from an observable price change for a similar investment of the same issuer; a $(1.8) million gain on the disposal of
assets of a small business in our United Kingdom region that are classified as held-for-sale; and a $(0.1) million
reimbursement for transition services provided to the buyers of certain of our discontinued operations.
(3) Represents expenses associated with our accelerated technology investment.
(4) For the three months ended September 30, 2021, consisted of the following adjustments: $12.0 million for certain legal and
regulatory expenses; and $0.4 million of net other consisting of net losses from currency remeasurement of our foreign
operations and other.
For the nine months ended September 30, 2021, consisted of the following adjustments: a $(20.4) million net reduction in
certain legal and regulatory expenses; a $(3.4) million recovery from the Fraud Incident, net of additional administrative
expense; and $1.6 million of net other consisting of net losses from currency remeasurement of our foreign operations and
other.
For the three months ended September 30, 2020, consisted of the following adjustments: $4.2 million for certain legal
expenses; and $(1.7) million of net gains from currency remeasurement of our foreign operations and other.

-- 10 of 12 --

As a result of displaying amounts in millions, rounding differences may exist in the table above.
As a result of displaying amounts in millions, rounding differences may exist in the table above.
For the nine months ended September 30, 2020, consisted of the following adjustments: $34.7 million for certain legal
expenses; and $0.7 million net other consisting of net losses from currency remeasurement of our foreign operations and other.
(5) Consisted of amortization of intangible assets from our 2012 change in control transaction and amortization of intangible
assets established in business acquisitions after our 2012 change in control transaction.
(6) As of September 30, 2021 and September 30, 2020, there were 0.1 million and 1.3 million contingently-issuable performance-
based stock awards outstanding in each respective period that were excluded from the diluted earnings per share calculation
because the contingencies had not been met.
SCHEDULE 4
TRANSUNION AND SUBSIDIARIES
Effective Tax Rate and Adjusted Effective Tax Rate (Unaudited)
(dollars in millions)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021 	2020 	2021 	2020
Income before income taxes 	$ 	157.2 	$ 	138.7 	$ 	510.7 	$ 	328.3
Total adjustments before income tax items from schedule 3 	100.0 	64.4 	225.6 	232.9
Noncontrolling interest portion of Adjusted Net Income
adjustments 	— 	(0.5) 	(2.0) 	(0.5)
Adjusted income before income taxes 	$ 	257.2 	$ 	202.6 	$ 	734.3 	$ 	560.8
(Provision) benefit for income taxes 	$ 	(39.0) $ 	(32.1) $ 	(129.1) $ 	(77.3)
Adjustments for income taxes:
Tax effect of above adjustments(1) 	(17.1) 	(13.8) 	(41.8) 	(49.5)
Eliminate impact of excess tax benefits for share
compensation(2) 	(1.2) 	(1.4) 	(9.1) 	(22.4)
Other(3) 	(1.6) 	4.2 	11.2 	21.3
Total adjustments for income taxes 	(19.9) 	(11.1) 	(39.8) 	(50.6)
Adjusted provision for income taxes 	$ 	(58.9) $ 	(43.1) $ 	(168.8) $ 	(127.9)
Effective tax rate 	24.8% 	23.1% 	25.3% 	23.5%
Adjusted Effective Tax Rate 	22.9% 	21.3% 	23.0% 	22.8%
(1) Tax rates used to calculate the tax expense impact are based on the nature of each item.
(2) Eliminates the impact of excess tax benefits for share compensation.
(3) Eliminates impact of state and foreign tax rate changes on deferred taxes, valuation allowances on foreign net operating
losses, capital losses and foreign tax credits and other discrete adjustments.
SCHEDULE 5
TRANSUNION AND SUBSIDIARIES
Segment Depreciation and Amortization (Unaudited)
(in millions)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021 	2020 	2021 	2020
U.S. Markets 	$ 	57.9 $ 	56.8 $ 	173.0 $ 	169.7
International 	32.6 	30.5 	99.7 	88.5
Consumer Interactive 	3.9 	3.5 	11.4 	10.9
Corporate 	1.4 	1.5 	4.4 	4.2
Total depreciation and amortization 	$ 	95.9 $ 	92.2 $ 	288.6 $ 	273.4

-- 11 of 12 --

As a result of displaying amounts in millions, rounding differences may exist in the table above.
SCHEDULE 6
TRANSUNION AND SUBSIDIARIES
Reconciliation of Non-GAAP Guidance (Unaudited)
(in millions, except per share data)
Three Months Ended
December 31, 2021
Twelve Months Ended
December 31, 2021
Low 	High 	Low 	High
Guidance reconciliation of net income attributable to
TransUnion to Adjusted EBITDA:
Net income attributable to TransUnion 	$ 	72 $ 	78 $ 	441 $ 	448
Interest, taxes and depreciation and amortization 	139 	140 	631 	632
EBITDA 	210 	218 	1,072 	1,080
Stock-based compensation, mergers, acquisitions divestitures
and business optimization-related expenses and other
adjustments(1) 	83 	83 	167 	167
Adjusted EBITDA 	$ 	293 $ 	301 $ 	1,239 $ 	1,247
Reconciliation of diluted earnings per share to Adjusted
Diluted Earnings per Share:
Diluted earnings per share 	$ 	0.37 $ 	0.40 $ 	2.29 $ 	2.32
Adjustments to diluted earnings per share(1) 	0.50 	0.50 	1.47 	1.47
Adjusted Diluted Earnings per Share 	$ 	0.88 $ 	0.91 $ 	3.76 $ 	3.79
(1) These adjustments include the same adjustments we make to our Adjusted EBITDA and Adjusted Net Income as discussed in
the Non-GAAP Financial Measures section of our Earnings Release.

-- 12 of 12 --